Article

Michael Fischer, MD, Discusses Non-Adherence

Michael Fischer, MD, associate professor of medicine, Harvard Medical School, associate physician, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, said that the complexity of the healthcare system is part of the challenge of managing adherence.

Michael Fischer, MD, associate professor of medicine, Harvard Medical School, associate physician, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, said that the complexity of the healthcare system is part of the challenge of managing adherence. Beyond a patient agreeing to and understanding how to take a medication, there must be coordination both with the pharmacy and the insurer.

“There are so many steps in the process and each of those is an area where we lose some patients from medication adherence,” said Dr Fischer. “Lack of understanding, maybe, of the diagnosis, lack of belief in the medications, complexity of the system, cost of the medications—each of those can be a threat to adherence, and figuring out how to address those effectively for each individual patient is really the challenge we all face at this point.”

Related Videos
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
AMCP Recap 2025
Giulio Cossu, MD
Lynae Darbes, PhD
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo